Fluocinonide Solution
Name: Fluocinonide Solution
Indications and Usage for Fluocinonide Solution
Fluocinonide Topical Solution USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Adverse Reactions
The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence:
Burning | Hypertrichosis | Maceration of the skin |
Itching | Acneiform eruptions | Secondary infection |
Irritation | Hypopigmentation | Skin atrophy |
Dryness | Perioral dermatitis | Striae |
Folliculitis | Allergic contact dermatitis | Miliaria |
Overdosage
Topically applied corticosteroids can be absorbed in sufficient amounts to produce systemic effects (See PRECAUTIONS).
Fluocinonide Solution Dosage and Administration
Fluocinonide Topical Solution USP, 0.05% is generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition.
Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.
If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
PRINCIPAL DISPLAY PANEL - 20 mL Bottle Carton
20 mL
NDC 51672-1273-2
Fluocinonide
Topical Solution
USP, 0.05%
FOR TOPICAL
USE ONLY.
NOT FOR
OPHTHALMIC USE.
Keep this and all
medications out of the
reach of children.
Rx only
TARO
PRINCIPAL DISPLAY PANEL - 20 mL Bottle Carton - Canada
20 mL
NDC 51672-1273-2
Fluocinonide
Topical Solution
USP, 0.05%
FOR TOPICAL
USE ONLY.
NOT FOR
OPHTHALMIC USE.
Keep this and all
medications out of the
reach of children.
Rx only
TARO
FLUOCINONIDE Fluocinonide Solution | |||||||||||||||||||
| |||||||||||||||||||
| |||||||||||||||||||
| |||||||||||||||||||
| |||||||||||||||||||
|
Labeler - Taro Pharmaceuticals U.S.A., Inc. (145186370) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Taro Pharmaceuticals Inc. | 206263295 | MANUFACTURE(51672-1273) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Taro Pharmaceutical Industries Ltd. | 600072078 | MANUFACTURE(51672-1273) |